--------------------------------------------------------------------------------
Robert Smith, [38]
--------------------------------------------------------------------------------
Any particular weather-related impacts in the first quarter or in the current quarter?
--------------------------------------------------------------------------------
Kevin Austin Hammill, Marrone Bio Innovations, Inc. - Chief Commercial Officer [39]
--------------------------------------------------------------------------------
This is Kevin again. There the team is probably rain. And so as we look at -- and I'll be repeating myself a bit, but I'll break it into basically 3 different markets. In the almond market, as I mentioned, we saw an uptick of market share whether Regalia for bloom spray. This is partially offset by a little bit lower rate reduction because they switched to aerial application to -- from ground rigs because they could not get the Regalia on the ground rigs. The California fruit and vegetable market was delayed planting because of the rain, but we see and that's progressing well, and we're actually seeing some good progress with their insecticides and fungicides in that market. As you know, the Midwest row crop growers are under extreme rain and flooding and our first thought goes out to them, and hopefully, they can get dry weather. Right now, we're not too concerned about this. And the reason is that there is a stat out there that takes about 14 days to plant the entire USA corn crop. And so we believe that if we get some dry weather, there's going to be ample runway or ample time for them to get all the corn acres they have planned to put in and all the soybean acres they've planned to put in. So right now, not a major impact to our business by our thoughts and hope for dry weather for our growers going forward here.
--------------------------------------------------------------------------------
Robert Smith, [40]
--------------------------------------------------------------------------------
Any kind of comments on 014 and Zequanox?
--------------------------------------------------------------------------------
Pamela G. Marrone, Marrone Bio Innovations, Inc. - Founder, CEO & Director [41]
--------------------------------------------------------------------------------
Sure. We're as excited as ever by 014. And what the R&D team is doing now is really focused on commercial applicability to all the things that we need to do to have a strong launch when it gets approved by EPA for both organic as well as conventional and conventional mixtures with other products. So -- and then we're doing the things that we do with each -- every product in terms of getting it ready for launch. In this case, we have chosen to invest a little bit more so we can have it even more effective for conventional when we launch. And as far as Zequanox, we're also still very excited by the potential of Zequanox. We have -- we're still focusing on 2 areas, which is pipe treatment in industrial power plants and also open water. And we have activities going in both areas. So we have customers like a big power plant in Illinois that we've been treating this season. So continuing a pipeline of customers. And Kevin and team have night -- a program that's designed to increase adoption in the pipe treatment area. And then we're working on the Great Lakes restoration. The government bodies and NGOs are still very keen on using Zequanox to treat parts of the shores of the Great Lakes, and we'll be making product to do some treatments this year. I don't know, Kevin, if you had any -- no? Okay. Do you want any comment on that? No? Okay.
--------------------------------------------------------------------------------
Robert Smith, [42]
--------------------------------------------------------------------------------
All right. And just finally the cannabis and hemp barrier seems to be moving so quickly and there's so much publicity about it, is there any way for you guys to get some association in the press? Or the commentary on field itself as far as being a player?
--------------------------------------------------------------------------------
Pamela G. Marrone, Marrone Bio Innovations, Inc. - Founder, CEO & Director [43]
--------------------------------------------------------------------------------
We -- I actually have got a number of interviews in Cannabis Times and other things, and we've been in some of the key cannabis press late -- earlier this year. We'll continue to focus on how biologicals can really help in this segment because a lot of -- they don't allow any chemicals in this and -- in cannabis and that we have a great, great products for this segment.
--------------------------------------------------------------------------------
Operator [44]
--------------------------------------------------------------------------------
That does conclude our question-and-answer session. I would like to turn the conference back over to Ms. Marrone for any additional or closing remarks.
--------------------------------------------------------------------------------
Pamela G. Marrone, Marrone Bio Innovations, Inc. - Founder, CEO & Director [45]
--------------------------------------------------------------------------------
Thank you, again, for joining us for the first quarter earnings call. While we're pleased with the start of the fiscal year, we are pressing hard on our strategic efforts to optimize our existing portfolio, expand our market reach and accelerate the potential of our R&D pipeline. Of course, as we continue to prudently invest for growth, we're working to effectively manage costs and working capital and conserve operating cash. Again, our thanks, and we look forward to speaking with you further about the potential of Marrone Bio Innovations. Thank you.
--------------------------------------------------------------------------------
Operator [46]
--------------------------------------------------------------------------------
Thank you. That does conclude today's conference. Thank you all for your participation. You may now disconnect.